| By Liu Yuanyuan, Asia Manufacturing Pharma |
| Wednesday, 23 July 2008 |
 |
Beijing Double-Crane Pharmaceutical Co., Ltd's (DCPC) subsidiary in Foshan, Guangdong province, was officially established recently, marking the completion of the construction of DCPC's national production network. To date, the company has set up several manufacturing facilities across China, with an annual production capacity of 860 million bottles or bags. |
|
Soft infusion bags have been regarded by insiders as a trend in the large infusion sector. Currently, soft bag infusion holds up to an 80 percent share of infusion markets in the Americas and in Europe while its market share in China has so far only reached 10 percent. However, analysts said that the share held by soft bag and plastic bottle infusion in |
|
|
the Chinese infusion market is likely to rise to 80 percent in five years as soft bags are expected to replace bottles gradually due to market demand as well as a preference by hospitals for soft bags, which are usually more expensive, under the current drug procurement model.
During last month, DCPC announced that the company acquired a 90 percent stake in Shenzhou Pharmaceutical Co., Ltd, a leading Chinese soft infusion producer with four soft bag infusion production lines, at the extremely low price of RMB2 (approximately US$0.30) per share.
Insiders indicated that the reason for DCPC's acquisition of Shenzhou Pharmaceutical is the latter's advantageous location in South China, where there is huge demand for large infusion. With the start of production at the new manufacturing |
|
facility in Foshan, DCPC's annual production capacity for soft bag infusion will nearly double, helping improve the company's overall infusion profitability, according to Cai Yueming, deputy general manager at the infusion division of DCPC.
DCPC plans to increase its share in Guangdong's infusion market to more than 50 percent over the next three years, added Cai.
_______________________________
Want to read more?
_______________________________
China’s infusion manufacturers advised to pay particular attention to packaging safety
Rosy future for pharmaceutical flexible packaging in China
German company upbeat about China’s quality pharmaceutical packaging market
|
|
|
